News Agency
The Times

Sirnaomics Announces Interim Data from Phase I Clinical Trial of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors

  • Written by PR Newswire

First three out of five cohorts pass safety requirements, allowing the Company to dose additional cohorts to assess safety, tolerability, pharmacokinetics and anti-tumor activity

HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Dec. 21, 2022 /PRNewswire/ -- Sirnaomics Ltd. (Stock Code: 2257.HK) (the "Company", together with its subsidiaries, "Sirnaomi...

Read more: Sirnaomics Announces Interim Data from Phase I Clinical Trial of RNAi Therapeutic STP707 for...

Why Shopify Web Development Is Important For Modern Online Stores

A successful online store requires more than attractive product images and basic functionality. Businesses need websites that load quickly, provide smooth navigation, and create a reliable shopping experience across all devices. Professional Shopify web development helps businesses build scalable eCommerce stores... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion